These findings suggest that metochalcone is a potential candidate within chalcone family for combating breast and lung cancers via modulation of the JAK2/STAT3 signaling pathway and targeting STAT3 to induce senescence-associated secretory phenotype. This evidence concerns the gene JAK2 and lung carcinoma.